In genetically engineered mouse models, PLD1 can modulate tumor progression (Chen et al., 2012; Kang et al., 2015) and similar effects have been reported for PLD2 (Henkels et al., 2013; Wang et al., 2017). Here, PLD2 is linked to neoplasm.